Experiment 69171

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismCimicifuga racemosa (RANUNCULACEAE)
CitationHERNANDEZ MUNOZ,G: PLUCHINO,S:. (2003). CIMICIFUGA RACEMOSA FOR THE TREATMENT OF HOT FLUSHES IN WOMEN SURVIVING BREAST CANCER.. 44(S1)
Amount utilized
Compound isolated
Disease136 BREAST CANCER SURVIVORS AGED 35-52 YEARS. AFTER TREATMENT WITH SEGMENTAL OR TOTAL MASTECTOMY, RADIATION THERAPY AND ADJUVANT CHEMOTHERAPY. HOT FLUSHES WERE THE MOST FREQUENT ADVERSE REACTION TO TAMOXIFEN ADJUVANT THERAPY IN BREAST CANCER SURVIVORS. THE COMBINED ADMINISTRATION OF TAMOXIFEN PLUS CR BNO 1055 FOR A PERIOD OF 12 MONTHS ALLOWED SATISFACTORY REDUCTION IN THE NUMBER AND SEVERITY OF HOT FLUSHES.
Dose amount20.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT
GenderFEMALE